← back to search

Norbert Stefan

Ludwig-Maximilians-Universität München · DE
🔎 Find collaborators in Epidemiology · Physiology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Epidemiology · Physiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Diabetes, Cardiovascular Risks, and Lipoproteins, Diet and metabolism studies, and Adipose Tissue and Metabolism.
h-index
95
citations
33,834
works
601
NIH funding
primary concept
Medicine
email

Recent publications

Prevention of type 2 diabetes through prediabetes remission without weight loss
Nature Medicine 2025cited by 19position: middledoi
Proteomic and Metabolomic Signatures in Prediabetes Progressing to Diabetes or Reversing to Normoglycemia Within 1 Year
Diabetes Care 2025cited by 11position: middledoi
Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes
Diabetologia 2025cited by 8position: middledoi
Refining visceral adipose tissue quantification: Influence of sex, age, and BMI on single slice estimation in 3D MRI of the German National Cohort
Zeitschrift für Medizinische Physik 2025cited by 0position: middledoi
Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature
Journal of Hepatology 2024cited by 33position: middledoi
Carrageenan and insulin resistance in humans: a randomised double-blind cross-over trial
BMC Medicine 2024cited by 13position: lastdoi
The role of hepatokines in NAFLD
Cell Metabolism 2023cited by 251position: firstdoi
Precision subclassification of type 2 diabetes: a systematic review
Communications Medicine 2023cited by 91position: middledoi
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)
The Lancet Diabetes & Endocrinology 2023cited by 81position: middledoi
Analysis of volume and topography of adipose tissue in the trunk: Results of MRI of 11,141 participants in the German National Cohort
Science Advances 2023cited by 14position: middledoi
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
Nature Reviews Endocrinology 2021cited by 457position: firstdoi
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
Nature Medicine 2021cited by 370position: middledoi
Elevated circulating follistatin associates with an increased risk of type 2 diabetes
Nature Communications 2021cited by 64position: middledoi
Obesity and impaired metabolic health in patients with COVID-19
Nature Reviews Endocrinology 2020cited by 659position: firstdoi
Causes, consequences, and treatment of metabolically unhealthy fat distribution
The Lancet Diabetes & Endocrinology 2020cited by 526position: firstdoi
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
Diabetes Care 2019cited by 336position: middledoi
Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study
The Lancet Diabetes & Endocrinology 2018cited by 461position: middledoi
Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis
Diabetes 2018cited by 22position: middledoi
Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies <i>BCL2</i> and <i>FAM19A2</i> as Novel Insulin Sensitivity Loci
Diabetes 2016cited by 83position: middledoi
S2k-Leitlinie nicht alkoholische Fettlebererkrankungen
Zeitschrift für Gastroenterologie 2015cited by 161position: middledoi
[S2k Guideline non-alcoholic fatty liver disease].
PubMed 2015cited by 111position: middledoi
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications
The Lancet Diabetes & Endocrinology 2013cited by 828position: firstdoi
Common Genetic Variation in the Human FNDC5 Locus, Encoding the Novel Muscle-Derived ‘Browning’ Factor Irisin, Determines Insulin Sensitivity
PLoS ONE 2013cited by 103position: middledoi
Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach
Diabetes 2012cited by 1,016position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andreas L. Birkenfeld · Phoenix Contact (Germany)8 papers (2019–2025)Jürgen Machann · Institute of Diabetes Research5 papers (2013–2025)Fritz Schick · Phoenix Contact (Germany)5 papers (2013–2025)Matthias B. Schulze · Robert Bosch (Germany)5 papers (2012–2021)Andreas Fritsche · Phoenix Contact (Germany)5 papers (2012–2025)Hans‐Ulrich Häring · Helmholtz Zentrum München5 papers (2012–2023)Michael Roden · Düsseldorf University Hospital4 papers (2012–2025)Martin Hrabě de Angelis · Helmholtz Zentrum München3 papers (2012–2021)Stefan R. Bornstein · Phoenix Contact (Germany)3 papers (2019–2025)Róbert Wágner · Düsseldorf University Hospital3 papers (2021–2025)Annette Peters · Bayer (Germany)3 papers (2012–2025)Ali Canbay · Charité - Universitätsmedizin Berlin2 papers (2015–2015) · 2 papers (2015–2015)Jochen Seißler · Ludwig-Maximilians-Universität München2 papers (2025–2025)Ulrich Baumann · Medizinische Hochschule Hannover2 papers (2015–2015)Susanne Rospleszcz · Deutsches Herzzentrum München2 papers (2023–2025)Tobias Haueise · University of Tübingen2 papers (2023–2025)Heike Bantel · University Medical Centre Mannheim2 papers (2015–2015)Hans‐Ulrich Kauczor · German Cancer Research Center2 papers (2023–2025)Klaus Maier‐Hein · German Cancer Research Center2 papers (2023–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Epidemiology · Physiology →